NCT06973681View on ClinicalTrials.gov

A Study of BGM0504 Evaluating Weight Loss in Overweight or Obese Chinese Subjects

PHASE2CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

October 13, 2023

Primary Completion Date

September 13, 2024

Study Completion Date

September 13, 2024

Conditions

Overweight or Obesity

Interventions

DRUG

BGM0504

Administered SC

DRUG

BGM0504

Administered SC

DRUG

BGM0504

Administered SC

DRUG

Placebo

Administered SC

Trial Locations (1)

Unknown

The Third Xiangya Hospital of Central South University, Changsha

All Listed Sponsors

lead

BrightGene Bio-Medical Technology Co., Ltd.

INDUSTRY

NCT06973681 - A Study of BGM0504 Evaluating Weight Loss in Overweight or Obese Chinese Subjects | Biotech Hunter | Biotech Hunter